COVID-19 Impact on Global Paclitaxel-eluting Stent Market Insights, Forecast to 2026
![](/report_cover/6975/covid-19-impact-on-global-paclitaxel-eluting-stent-market-insights-forecast-to-2026_en.gif)
Paclitaxel-eluting Stent market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Paclitaxel-eluting Stent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Paclitaxel-eluting Stent market is segmented into
The Paclitaxel-eluting Stent market is analysed and market size information is provided by regions (countries).
The key regions covered in the Paclitaxel-eluting Stent market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Paclitaxel-eluting Stent Market Share Analysis
Paclitaxel-eluting Stent market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Paclitaxel-eluting Stent by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Paclitaxel-eluting Stent business, the date to enter into the Paclitaxel-eluting Stent market, Paclitaxel-eluting Stent product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Paclitaxel-eluting Stent market is segmented into
- Metal Stent
- Polymer Stent
- Others
- Coronary Heart Disease
- Clinical
- Others
The Paclitaxel-eluting Stent market is analysed and market size information is provided by regions (countries).
The key regions covered in the Paclitaxel-eluting Stent market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Paclitaxel-eluting Stent Market Share Analysis
Paclitaxel-eluting Stent market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Paclitaxel-eluting Stent by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Paclitaxel-eluting Stent business, the date to enter into the Paclitaxel-eluting Stent market, Paclitaxel-eluting Stent product introduction, recent developments, etc.
The major vendors covered:
- B.Braun Melsengen AG
- Biosensors
- Biotronik
- Blue Medical
- Boston Scientific
- DISA Vascular
- Essen
- Medtronic Vascular
- MicroPort Medical
- Terumo Medical
1 STUDY COVERAGE
1.1 Paclitaxel-eluting Stent Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Paclitaxel-eluting Stent Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Type
1.4.2 Metal Stent
1.4.3 Polymer Stent
1.4.4 Others
1.5 Market by Application
1.5.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Application
1.5.2 Coronary Heart Disease
1.5.3 Clinical
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Paclitaxel-eluting Stent Industry Impact
1.6.1 How the Covid-19 is Affecting the Paclitaxel-eluting Stent Industry
1.6.1.1 Paclitaxel-eluting Stent Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Paclitaxel-eluting Stent Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Paclitaxel-eluting Stent Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Paclitaxel-eluting Stent Market Size Estimates and Forecasts
2.1.1 Global Paclitaxel-eluting Stent Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Paclitaxel-eluting Stent Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Paclitaxel-eluting Stent Production Estimates and Forecasts 2015-2026
2.2 Global Paclitaxel-eluting Stent Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Paclitaxel-eluting Stent Manufacturers Geographical Distribution
2.4 Key Trends for Paclitaxel-eluting Stent Markets & Products
2.5 Primary Interviews with Key Paclitaxel-eluting Stent Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Paclitaxel-eluting Stent Manufacturers by Production Capacity
3.1.1 Global Top Paclitaxel-eluting Stent Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Paclitaxel-eluting Stent Manufacturers by Production (2015-2020)
3.1.3 Global Top Paclitaxel-eluting Stent Manufacturers Market Share by Production
3.2 Global Top Paclitaxel-eluting Stent Manufacturers by Revenue
3.2.1 Global Top Paclitaxel-eluting Stent Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Paclitaxel-eluting Stent Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Paclitaxel-eluting Stent Revenue in 2019
3.3 Global Paclitaxel-eluting Stent Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 PACLITAXEL-ELUTING STENT PRODUCTION BY REGIONS
4.1 Global Paclitaxel-eluting Stent Historic Market Facts & Figures by Regions
4.1.1 Global Top Paclitaxel-eluting Stent Regions by Production (2015-2020)
4.1.2 Global Top Paclitaxel-eluting Stent Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Paclitaxel-eluting Stent Production (2015-2020)
4.2.2 North America Paclitaxel-eluting Stent Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Paclitaxel-eluting Stent Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Paclitaxel-eluting Stent Production (2015-2020)
4.3.2 Europe Paclitaxel-eluting Stent Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Paclitaxel-eluting Stent Import & Export (2015-2020)
4.4 China
4.4.1 China Paclitaxel-eluting Stent Production (2015-2020)
4.4.2 China Paclitaxel-eluting Stent Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Paclitaxel-eluting Stent Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Paclitaxel-eluting Stent Production (2015-2020)
4.5.2 Japan Paclitaxel-eluting Stent Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Paclitaxel-eluting Stent Import & Export (2015-2020)
5 PACLITAXEL-ELUTING STENT CONSUMPTION BY REGION
5.1 Global Top Paclitaxel-eluting Stent Regions by Consumption
5.1.1 Global Top Paclitaxel-eluting Stent Regions by Consumption (2015-2020)
5.1.2 Global Top Paclitaxel-eluting Stent Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Paclitaxel-eluting Stent Consumption by Application
5.2.2 North America Paclitaxel-eluting Stent Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Paclitaxel-eluting Stent Consumption by Application
5.3.2 Europe Paclitaxel-eluting Stent Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Paclitaxel-eluting Stent Consumption by Application
5.4.2 Asia Pacific Paclitaxel-eluting Stent Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Paclitaxel-eluting Stent Consumption by Application
5.5.2 Central & South America Paclitaxel-eluting Stent Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Paclitaxel-eluting Stent Consumption by Application
5.6.2 Middle East and Africa Paclitaxel-eluting Stent Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Paclitaxel-eluting Stent Market Size by Type (2015-2020)
6.1.1 Global Paclitaxel-eluting Stent Production by Type (2015-2020)
6.1.2 Global Paclitaxel-eluting Stent Revenue by Type (2015-2020)
6.1.3 Paclitaxel-eluting Stent Price by Type (2015-2020)
6.2 Global Paclitaxel-eluting Stent Market Forecast by Type (2021-2026)
6.2.1 Global Paclitaxel-eluting Stent Production Forecast by Type (2021-2026)
6.2.2 Global Paclitaxel-eluting Stent Revenue Forecast by Type (2021-2026)
6.2.3 Global Paclitaxel-eluting Stent Price Forecast by Type (2021-2026)
6.3 Global Paclitaxel-eluting Stent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Paclitaxel-eluting Stent Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Paclitaxel-eluting Stent Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 B.Braun Melsengen AG
8.1.1 B.Braun Melsengen AG Corporation Information
8.1.2 B.Braun Melsengen AG Overview and Its Total Revenue
8.1.3 B.Braun Melsengen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 B.Braun Melsengen AG Product Description
8.1.5 B.Braun Melsengen AG Recent Development
8.2 Biosensors
8.2.1 Biosensors Corporation Information
8.2.2 Biosensors Overview and Its Total Revenue
8.2.3 Biosensors Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Biosensors Product Description
8.2.5 Biosensors Recent Development
8.3 Biotronik
8.3.1 Biotronik Corporation Information
8.3.2 Biotronik Overview and Its Total Revenue
8.3.3 Biotronik Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Biotronik Product Description
8.3.5 Biotronik Recent Development
8.4 Blue Medical
8.4.1 Blue Medical Corporation Information
8.4.2 Blue Medical Overview and Its Total Revenue
8.4.3 Blue Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Blue Medical Product Description
8.4.5 Blue Medical Recent Development
8.5 Boston Scientific
8.5.1 Boston Scientific Corporation Information
8.5.2 Boston Scientific Overview and Its Total Revenue
8.5.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Boston Scientific Product Description
8.5.5 Boston Scientific Recent Development
8.6 DISA Vascular
8.6.1 DISA Vascular Corporation Information
8.6.2 DISA Vascular Overview and Its Total Revenue
8.6.3 DISA Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 DISA Vascular Product Description
8.6.5 DISA Vascular Recent Development
8.7 Essen
8.7.1 Essen Corporation Information
8.7.2 Essen Overview and Its Total Revenue
8.7.3 Essen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Essen Product Description
8.7.5 Essen Recent Development
8.8 Medtronic Vascular
8.8.1 Medtronic Vascular Corporation Information
8.8.2 Medtronic Vascular Overview and Its Total Revenue
8.8.3 Medtronic Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Medtronic Vascular Product Description
8.8.5 Medtronic Vascular Recent Development
8.9 MicroPort Medical
8.9.1 MicroPort Medical Corporation Information
8.9.2 MicroPort Medical Overview and Its Total Revenue
8.9.3 MicroPort Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 MicroPort Medical Product Description
8.9.5 MicroPort Medical Recent Development
8.10 Terumo Medical
8.10.1 Terumo Medical Corporation Information
8.10.2 Terumo Medical Overview and Its Total Revenue
8.10.3 Terumo Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Terumo Medical Product Description
8.10.5 Terumo Medical Recent Development
8.11 Orbusneich
8.11.1 Orbusneich Corporation Information
8.11.2 Orbusneich Overview and Its Total Revenue
8.11.3 Orbusneich Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Orbusneich Product Description
8.11.5 Orbusneich Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Paclitaxel-eluting Stent Regions Forecast by Revenue (2021-2026)
9.2 Global Top Paclitaxel-eluting Stent Regions Forecast by Production (2021-2026)
9.3 Key Paclitaxel-eluting Stent Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 PACLITAXEL-ELUTING STENT CONSUMPTION FORECAST BY REGION
10.1 Global Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.2 North America Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.3 Europe Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.5 Latin America Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Paclitaxel-eluting Stent Sales Channels
11.2.2 Paclitaxel-eluting Stent Distributors
11.3 Paclitaxel-eluting Stent Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL PACLITAXEL-ELUTING STENT STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Paclitaxel-eluting Stent Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Paclitaxel-eluting Stent Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Type
1.4.2 Metal Stent
1.4.3 Polymer Stent
1.4.4 Others
1.5 Market by Application
1.5.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Application
1.5.2 Coronary Heart Disease
1.5.3 Clinical
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Paclitaxel-eluting Stent Industry Impact
1.6.1 How the Covid-19 is Affecting the Paclitaxel-eluting Stent Industry
1.6.1.1 Paclitaxel-eluting Stent Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Paclitaxel-eluting Stent Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Paclitaxel-eluting Stent Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Paclitaxel-eluting Stent Market Size Estimates and Forecasts
2.1.1 Global Paclitaxel-eluting Stent Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Paclitaxel-eluting Stent Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Paclitaxel-eluting Stent Production Estimates and Forecasts 2015-2026
2.2 Global Paclitaxel-eluting Stent Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Paclitaxel-eluting Stent Manufacturers Geographical Distribution
2.4 Key Trends for Paclitaxel-eluting Stent Markets & Products
2.5 Primary Interviews with Key Paclitaxel-eluting Stent Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Paclitaxel-eluting Stent Manufacturers by Production Capacity
3.1.1 Global Top Paclitaxel-eluting Stent Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Paclitaxel-eluting Stent Manufacturers by Production (2015-2020)
3.1.3 Global Top Paclitaxel-eluting Stent Manufacturers Market Share by Production
3.2 Global Top Paclitaxel-eluting Stent Manufacturers by Revenue
3.2.1 Global Top Paclitaxel-eluting Stent Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Paclitaxel-eluting Stent Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Paclitaxel-eluting Stent Revenue in 2019
3.3 Global Paclitaxel-eluting Stent Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 PACLITAXEL-ELUTING STENT PRODUCTION BY REGIONS
4.1 Global Paclitaxel-eluting Stent Historic Market Facts & Figures by Regions
4.1.1 Global Top Paclitaxel-eluting Stent Regions by Production (2015-2020)
4.1.2 Global Top Paclitaxel-eluting Stent Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Paclitaxel-eluting Stent Production (2015-2020)
4.2.2 North America Paclitaxel-eluting Stent Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Paclitaxel-eluting Stent Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Paclitaxel-eluting Stent Production (2015-2020)
4.3.2 Europe Paclitaxel-eluting Stent Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Paclitaxel-eluting Stent Import & Export (2015-2020)
4.4 China
4.4.1 China Paclitaxel-eluting Stent Production (2015-2020)
4.4.2 China Paclitaxel-eluting Stent Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Paclitaxel-eluting Stent Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Paclitaxel-eluting Stent Production (2015-2020)
4.5.2 Japan Paclitaxel-eluting Stent Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Paclitaxel-eluting Stent Import & Export (2015-2020)
5 PACLITAXEL-ELUTING STENT CONSUMPTION BY REGION
5.1 Global Top Paclitaxel-eluting Stent Regions by Consumption
5.1.1 Global Top Paclitaxel-eluting Stent Regions by Consumption (2015-2020)
5.1.2 Global Top Paclitaxel-eluting Stent Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Paclitaxel-eluting Stent Consumption by Application
5.2.2 North America Paclitaxel-eluting Stent Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Paclitaxel-eluting Stent Consumption by Application
5.3.2 Europe Paclitaxel-eluting Stent Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Paclitaxel-eluting Stent Consumption by Application
5.4.2 Asia Pacific Paclitaxel-eluting Stent Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Paclitaxel-eluting Stent Consumption by Application
5.5.2 Central & South America Paclitaxel-eluting Stent Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Paclitaxel-eluting Stent Consumption by Application
5.6.2 Middle East and Africa Paclitaxel-eluting Stent Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Paclitaxel-eluting Stent Market Size by Type (2015-2020)
6.1.1 Global Paclitaxel-eluting Stent Production by Type (2015-2020)
6.1.2 Global Paclitaxel-eluting Stent Revenue by Type (2015-2020)
6.1.3 Paclitaxel-eluting Stent Price by Type (2015-2020)
6.2 Global Paclitaxel-eluting Stent Market Forecast by Type (2021-2026)
6.2.1 Global Paclitaxel-eluting Stent Production Forecast by Type (2021-2026)
6.2.2 Global Paclitaxel-eluting Stent Revenue Forecast by Type (2021-2026)
6.2.3 Global Paclitaxel-eluting Stent Price Forecast by Type (2021-2026)
6.3 Global Paclitaxel-eluting Stent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Paclitaxel-eluting Stent Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Paclitaxel-eluting Stent Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 B.Braun Melsengen AG
8.1.1 B.Braun Melsengen AG Corporation Information
8.1.2 B.Braun Melsengen AG Overview and Its Total Revenue
8.1.3 B.Braun Melsengen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 B.Braun Melsengen AG Product Description
8.1.5 B.Braun Melsengen AG Recent Development
8.2 Biosensors
8.2.1 Biosensors Corporation Information
8.2.2 Biosensors Overview and Its Total Revenue
8.2.3 Biosensors Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Biosensors Product Description
8.2.5 Biosensors Recent Development
8.3 Biotronik
8.3.1 Biotronik Corporation Information
8.3.2 Biotronik Overview and Its Total Revenue
8.3.3 Biotronik Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Biotronik Product Description
8.3.5 Biotronik Recent Development
8.4 Blue Medical
8.4.1 Blue Medical Corporation Information
8.4.2 Blue Medical Overview and Its Total Revenue
8.4.3 Blue Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Blue Medical Product Description
8.4.5 Blue Medical Recent Development
8.5 Boston Scientific
8.5.1 Boston Scientific Corporation Information
8.5.2 Boston Scientific Overview and Its Total Revenue
8.5.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Boston Scientific Product Description
8.5.5 Boston Scientific Recent Development
8.6 DISA Vascular
8.6.1 DISA Vascular Corporation Information
8.6.2 DISA Vascular Overview and Its Total Revenue
8.6.3 DISA Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 DISA Vascular Product Description
8.6.5 DISA Vascular Recent Development
8.7 Essen
8.7.1 Essen Corporation Information
8.7.2 Essen Overview and Its Total Revenue
8.7.3 Essen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Essen Product Description
8.7.5 Essen Recent Development
8.8 Medtronic Vascular
8.8.1 Medtronic Vascular Corporation Information
8.8.2 Medtronic Vascular Overview and Its Total Revenue
8.8.3 Medtronic Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Medtronic Vascular Product Description
8.8.5 Medtronic Vascular Recent Development
8.9 MicroPort Medical
8.9.1 MicroPort Medical Corporation Information
8.9.2 MicroPort Medical Overview and Its Total Revenue
8.9.3 MicroPort Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 MicroPort Medical Product Description
8.9.5 MicroPort Medical Recent Development
8.10 Terumo Medical
8.10.1 Terumo Medical Corporation Information
8.10.2 Terumo Medical Overview and Its Total Revenue
8.10.3 Terumo Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Terumo Medical Product Description
8.10.5 Terumo Medical Recent Development
8.11 Orbusneich
8.11.1 Orbusneich Corporation Information
8.11.2 Orbusneich Overview and Its Total Revenue
8.11.3 Orbusneich Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Orbusneich Product Description
8.11.5 Orbusneich Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Paclitaxel-eluting Stent Regions Forecast by Revenue (2021-2026)
9.2 Global Top Paclitaxel-eluting Stent Regions Forecast by Production (2021-2026)
9.3 Key Paclitaxel-eluting Stent Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 PACLITAXEL-ELUTING STENT CONSUMPTION FORECAST BY REGION
10.1 Global Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.2 North America Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.3 Europe Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.5 Latin America Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Paclitaxel-eluting Stent Sales Channels
11.2.2 Paclitaxel-eluting Stent Distributors
11.3 Paclitaxel-eluting Stent Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL PACLITAXEL-ELUTING STENT STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Paclitaxel-eluting Stent Key Market Segments in This Study
Table 2. Ranking of Global Top Paclitaxel-eluting Stent Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Paclitaxel-eluting Stent Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Metal Stent
Table 5. Major Manufacturers of Polymer Stent
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Paclitaxel-eluting Stent Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Paclitaxel-eluting Stent Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Paclitaxel-eluting Stent Players to Combat Covid-19 Impact
Table 12. Global Paclitaxel-eluting Stent Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Paclitaxel-eluting Stent Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Paclitaxel-eluting Stent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel-eluting Stent as of 2019)
Table 16. Paclitaxel-eluting Stent Manufacturing Base Distribution and Headquarters
Table 17. Manufacturers Paclitaxel-eluting Stent Product Offered
Table 18. Date of Manufacturers Enter into Paclitaxel-eluting Stent Market
Table 19. Key Trends for Paclitaxel-eluting Stent Markets & Products
Table 20. Main Points Interviewed from Key Paclitaxel-eluting Stent Players
Table 21. Global Paclitaxel-eluting Stent Production Capacity by Manufacturers (2015-2020) (K Units)
Table 22. Global Paclitaxel-eluting Stent Production Share by Manufacturers (2015-2020)
Table 23. Paclitaxel-eluting Stent Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Paclitaxel-eluting Stent Revenue Share by Manufacturers (2015-2020)
Table 25. Paclitaxel-eluting Stent Price by Manufacturers 2015-2020 (USD/Unit)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Paclitaxel-eluting Stent Production by Regions (2015-2020) (K Units)
Table 28. Global Paclitaxel-eluting Stent Production Market Share by Regions (2015-2020)
Table 29. Global Paclitaxel-eluting Stent Revenue by Regions (2015-2020) (US$ Million)
Table 30. Global Paclitaxel-eluting Stent Revenue Market Share by Regions (2015-2020)
Table 31. Key Paclitaxel-eluting Stent Players in North America
Table 32. Import & Export of Paclitaxel-eluting Stent in North America (K Units)
Table 33. Key Paclitaxel-eluting Stent Players in Europe
Table 34. Import & Export of Paclitaxel-eluting Stent in Europe (K Units)
Table 35. Key Paclitaxel-eluting Stent Players in China
Table 36. Import & Export of Paclitaxel-eluting Stent in China (K Units)
Table 37. Key Paclitaxel-eluting Stent Players in Japan
Table 38. Import & Export of Paclitaxel-eluting Stent in Japan (K Units)
Table 39. Global Paclitaxel-eluting Stent Consumption by Regions (2015-2020) (K Units)
Table 40. Global Paclitaxel-eluting Stent Consumption Market Share by Regions (2015-2020)
Table 41. North America Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 42. North America Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 43. Europe Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 44. Europe Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 45. Asia Pacific Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 46. Asia Pacific Paclitaxel-eluting Stent Consumption Market Share by Application (2015-2020) (K Units)
Table 47. Asia Pacific Paclitaxel-eluting Stent Consumption by Regions (2015-2020) (K Units)
Table 48. Latin America Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 49. Latin America Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 50. Middle East and Africa Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 51. Middle East and Africa Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 52. Global Paclitaxel-eluting Stent Production by Type (2015-2020) (K Units)
Table 53. Global Paclitaxel-eluting Stent Production Share by Type (2015-2020)
Table 54. Global Paclitaxel-eluting Stent Revenue by Type (2015-2020) (Million US$)
Table 55. Global Paclitaxel-eluting Stent Revenue Share by Type (2015-2020)
Table 56. Paclitaxel-eluting Stent Price by Type 2015-2020 (USD/Unit)
Table 57. Global Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 58. Global Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 59. Global Paclitaxel-eluting Stent Consumption Share by Application (2015-2020)
Table 60. B.Braun Melsengen AG Corporation Information
Table 61. B.Braun Melsengen AG Description and Major Businesses
Table 62. B.Braun Melsengen AG Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. B.Braun Melsengen AG Product
Table 64. B.Braun Melsengen AG Recent Development
Table 65. Biosensors Corporation Information
Table 66. Biosensors Description and Major Businesses
Table 67. Biosensors Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. Biosensors Product
Table 69. Biosensors Recent Development
Table 70. Biotronik Corporation Information
Table 71. Biotronik Description and Major Businesses
Table 72. Biotronik Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Biotronik Product
Table 74. Biotronik Recent Development
Table 75. Blue Medical Corporation Information
Table 76. Blue Medical Description and Major Businesses
Table 77. Blue Medical Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Blue Medical Product
Table 79. Blue Medical Recent Development
Table 80. Boston Scientific Corporation Information
Table 81. Boston Scientific Description and Major Businesses
Table 82. Boston Scientific Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Boston Scientific Product
Table 84. Boston Scientific Recent Development
Table 85. DISA Vascular Corporation Information
Table 86. DISA Vascular Description and Major Businesses
Table 87. DISA Vascular Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. DISA Vascular Product
Table 89. DISA Vascular Recent Development
Table 90. Essen Corporation Information
Table 91. Essen Description and Major Businesses
Table 92. Essen Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Essen Product
Table 94. Essen Recent Development
Table 95. Medtronic Vascular Corporation Information
Table 96. Medtronic Vascular Description and Major Businesses
Table 97. Medtronic Vascular Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Medtronic Vascular Product
Table 99. Medtronic Vascular Recent Development
Table 100. MicroPort Medical Corporation Information
Table 101. MicroPort Medical Description and Major Businesses
Table 102. MicroPort Medical Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. MicroPort Medical Product
Table 104. MicroPort Medical Recent Development
Table 105. Terumo Medical Corporation Information
Table 106. Terumo Medical Description and Major Businesses
Table 107. Terumo Medical Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Terumo Medical Product
Table 109. Terumo Medical Recent Development
Table 110. Orbusneich Corporation Information
Table 111. Orbusneich Description and Major Businesses
Table 112. Orbusneich Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Orbusneich Product
Table 114. Orbusneich Recent Development
Table 115. Global Paclitaxel-eluting Stent Revenue Forecast by Region (2021-2026) (Million US$)
Table 116. Global Paclitaxel-eluting Stent Production Forecast by Regions (2021-2026) (K Units)
Table 117. Global Paclitaxel-eluting Stent Production Forecast by Type (2021-2026) (K Units)
Table 118. Global Paclitaxel-eluting Stent Revenue Forecast by Type (2021-2026) (Million US$)
Table 119. North America Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 120. Europe Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 121. Asia Pacific Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 122. Latin America Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 123. Middle East and Africa Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 124. Paclitaxel-eluting Stent Distributors List
Table 125. Paclitaxel-eluting Stent Customers List
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 1. Paclitaxel-eluting Stent Key Market Segments in This Study
Table 2. Ranking of Global Top Paclitaxel-eluting Stent Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Paclitaxel-eluting Stent Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Metal Stent
Table 5. Major Manufacturers of Polymer Stent
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Paclitaxel-eluting Stent Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Paclitaxel-eluting Stent Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Paclitaxel-eluting Stent Players to Combat Covid-19 Impact
Table 12. Global Paclitaxel-eluting Stent Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Paclitaxel-eluting Stent Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Paclitaxel-eluting Stent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel-eluting Stent as of 2019)
Table 16. Paclitaxel-eluting Stent Manufacturing Base Distribution and Headquarters
Table 17. Manufacturers Paclitaxel-eluting Stent Product Offered
Table 18. Date of Manufacturers Enter into Paclitaxel-eluting Stent Market
Table 19. Key Trends for Paclitaxel-eluting Stent Markets & Products
Table 20. Main Points Interviewed from Key Paclitaxel-eluting Stent Players
Table 21. Global Paclitaxel-eluting Stent Production Capacity by Manufacturers (2015-2020) (K Units)
Table 22. Global Paclitaxel-eluting Stent Production Share by Manufacturers (2015-2020)
Table 23. Paclitaxel-eluting Stent Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Paclitaxel-eluting Stent Revenue Share by Manufacturers (2015-2020)
Table 25. Paclitaxel-eluting Stent Price by Manufacturers 2015-2020 (USD/Unit)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Paclitaxel-eluting Stent Production by Regions (2015-2020) (K Units)
Table 28. Global Paclitaxel-eluting Stent Production Market Share by Regions (2015-2020)
Table 29. Global Paclitaxel-eluting Stent Revenue by Regions (2015-2020) (US$ Million)
Table 30. Global Paclitaxel-eluting Stent Revenue Market Share by Regions (2015-2020)
Table 31. Key Paclitaxel-eluting Stent Players in North America
Table 32. Import & Export of Paclitaxel-eluting Stent in North America (K Units)
Table 33. Key Paclitaxel-eluting Stent Players in Europe
Table 34. Import & Export of Paclitaxel-eluting Stent in Europe (K Units)
Table 35. Key Paclitaxel-eluting Stent Players in China
Table 36. Import & Export of Paclitaxel-eluting Stent in China (K Units)
Table 37. Key Paclitaxel-eluting Stent Players in Japan
Table 38. Import & Export of Paclitaxel-eluting Stent in Japan (K Units)
Table 39. Global Paclitaxel-eluting Stent Consumption by Regions (2015-2020) (K Units)
Table 40. Global Paclitaxel-eluting Stent Consumption Market Share by Regions (2015-2020)
Table 41. North America Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 42. North America Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 43. Europe Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 44. Europe Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 45. Asia Pacific Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 46. Asia Pacific Paclitaxel-eluting Stent Consumption Market Share by Application (2015-2020) (K Units)
Table 47. Asia Pacific Paclitaxel-eluting Stent Consumption by Regions (2015-2020) (K Units)
Table 48. Latin America Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 49. Latin America Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 50. Middle East and Africa Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 51. Middle East and Africa Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 52. Global Paclitaxel-eluting Stent Production by Type (2015-2020) (K Units)
Table 53. Global Paclitaxel-eluting Stent Production Share by Type (2015-2020)
Table 54. Global Paclitaxel-eluting Stent Revenue by Type (2015-2020) (Million US$)
Table 55. Global Paclitaxel-eluting Stent Revenue Share by Type (2015-2020)
Table 56. Paclitaxel-eluting Stent Price by Type 2015-2020 (USD/Unit)
Table 57. Global Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 58. Global Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 59. Global Paclitaxel-eluting Stent Consumption Share by Application (2015-2020)
Table 60. B.Braun Melsengen AG Corporation Information
Table 61. B.Braun Melsengen AG Description and Major Businesses
Table 62. B.Braun Melsengen AG Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. B.Braun Melsengen AG Product
Table 64. B.Braun Melsengen AG Recent Development
Table 65. Biosensors Corporation Information
Table 66. Biosensors Description and Major Businesses
Table 67. Biosensors Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. Biosensors Product
Table 69. Biosensors Recent Development
Table 70. Biotronik Corporation Information
Table 71. Biotronik Description and Major Businesses
Table 72. Biotronik Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Biotronik Product
Table 74. Biotronik Recent Development
Table 75. Blue Medical Corporation Information
Table 76. Blue Medical Description and Major Businesses
Table 77. Blue Medical Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Blue Medical Product
Table 79. Blue Medical Recent Development
Table 80. Boston Scientific Corporation Information
Table 81. Boston Scientific Description and Major Businesses
Table 82. Boston Scientific Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Boston Scientific Product
Table 84. Boston Scientific Recent Development
Table 85. DISA Vascular Corporation Information
Table 86. DISA Vascular Description and Major Businesses
Table 87. DISA Vascular Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. DISA Vascular Product
Table 89. DISA Vascular Recent Development
Table 90. Essen Corporation Information
Table 91. Essen Description and Major Businesses
Table 92. Essen Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Essen Product
Table 94. Essen Recent Development
Table 95. Medtronic Vascular Corporation Information
Table 96. Medtronic Vascular Description and Major Businesses
Table 97. Medtronic Vascular Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Medtronic Vascular Product
Table 99. Medtronic Vascular Recent Development
Table 100. MicroPort Medical Corporation Information
Table 101. MicroPort Medical Description and Major Businesses
Table 102. MicroPort Medical Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. MicroPort Medical Product
Table 104. MicroPort Medical Recent Development
Table 105. Terumo Medical Corporation Information
Table 106. Terumo Medical Description and Major Businesses
Table 107. Terumo Medical Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Terumo Medical Product
Table 109. Terumo Medical Recent Development
Table 110. Orbusneich Corporation Information
Table 111. Orbusneich Description and Major Businesses
Table 112. Orbusneich Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Orbusneich Product
Table 114. Orbusneich Recent Development
Table 115. Global Paclitaxel-eluting Stent Revenue Forecast by Region (2021-2026) (Million US$)
Table 116. Global Paclitaxel-eluting Stent Production Forecast by Regions (2021-2026) (K Units)
Table 117. Global Paclitaxel-eluting Stent Production Forecast by Type (2021-2026) (K Units)
Table 118. Global Paclitaxel-eluting Stent Revenue Forecast by Type (2021-2026) (Million US$)
Table 119. North America Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 120. Europe Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 121. Asia Pacific Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 122. Latin America Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 123. Middle East and Africa Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 124. Paclitaxel-eluting Stent Distributors List
Table 125. Paclitaxel-eluting Stent Customers List
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Paclitaxel-eluting Stent Product Picture
Figure 2. Global Paclitaxel-eluting Stent Production Market Share by Type in 2020 & 2026
Figure 3. Metal Stent Product Picture
Figure 4. Polymer Stent Product Picture
Figure 5. Others Product Picture
Figure 6. Global Paclitaxel-eluting Stent Consumption Market Share by Application in 2020 & 2026
Figure 7. Coronary Heart Disease
Figure 8. Clinical
Figure 9. Others
Figure 10. Paclitaxel-eluting Stent Report Years Considered
Figure 11. Global Paclitaxel-eluting Stent Revenue 2015-2026 (Million US$)
Figure 12. Global Paclitaxel-eluting Stent Production Capacity 2015-2026 (K Units)
Figure 13. Global Paclitaxel-eluting Stent Production 2015-2026 (K Units)
Figure 14. Global Paclitaxel-eluting Stent Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 15. Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Paclitaxel-eluting Stent Production Share by Manufacturers in 2015
Figure 17. The Top 10 and Top 5 Players Market Share by Paclitaxel-eluting Stent Revenue in 2019
Figure 18. Global Paclitaxel-eluting Stent Production Market Share by Region (2015-2020)
Figure 19. Paclitaxel-eluting Stent Production Growth Rate in North America (2015-2020) (K Units)
Figure 20. Paclitaxel-eluting Stent Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 21. Paclitaxel-eluting Stent Production Growth Rate in Europe (2015-2020) (K Units)
Figure 22. Paclitaxel-eluting Stent Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 23. Paclitaxel-eluting Stent Production Growth Rate in China (2015-2020) (K Units)
Figure 24. Paclitaxel-eluting Stent Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 25. Paclitaxel-eluting Stent Production Growth Rate in Japan (2015-2020) (K Units)
Figure 26. Paclitaxel-eluting Stent Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 27. Global Paclitaxel-eluting Stent Consumption Market Share by Regions 2015-2020
Figure 28. North America Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 29. North America Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 30. North America Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 31. U.S. Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Canada Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 35. Europe Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 36. Germany Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. France Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. U.K. Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Italy Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Russia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Asia Pacific Paclitaxel-eluting Stent Consumption and Growth Rate (K Units)
Figure 42. Asia Pacific Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 43. Asia Pacific Paclitaxel-eluting Stent Consumption Market Share by Regions in 2019
Figure 44. China Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Japan Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. India Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Australia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Taiwan Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Indonesia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Thailand Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Malaysia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Philippines Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Vietnam Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Latin America Paclitaxel-eluting Stent Consumption and Growth Rate (K Units)
Figure 56. Latin America Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 57. Latin America Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 58. Mexico Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Brazil Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Argentina Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Middle East and Africa Paclitaxel-eluting Stent Consumption and Growth Rate (K Units)
Figure 62. Middle East and Africa Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 63. Middle East and Africa Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 64. Turkey Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Saudi Arabia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. U.A.E Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Global Paclitaxel-eluting Stent Production Market Share by Type (2015-2020)
Figure 68. Global Paclitaxel-eluting Stent Production Market Share by Type in 2019
Figure 69. Global Paclitaxel-eluting Stent Revenue Market Share by Type (2015-2020)
Figure 70. Global Paclitaxel-eluting Stent Revenue Market Share by Type in 2019
Figure 71. Global Paclitaxel-eluting Stent Production Market Share Forecast by Type (2021-2026)
Figure 72. Global Paclitaxel-eluting Stent Revenue Market Share Forecast by Type (2021-2026)
Figure 73. Global Paclitaxel-eluting Stent Market Share by Price Range (2015-2020)
Figure 74. Global Paclitaxel-eluting Stent Consumption Market Share by Application (2015-2020)
Figure 75. Global Paclitaxel-eluting Stent Value (Consumption) Market Share by Application (2015-2020)
Figure 76. Global Paclitaxel-eluting Stent Consumption Market Share Forecast by Application (2021-2026)
Figure 77. B.Braun Melsengen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Biosensors Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Biotronik Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Blue Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. DISA Vascular Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Essen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Medtronic Vascular Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. MicroPort Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Terumo Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Orbusneich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Global Paclitaxel-eluting Stent Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 89. Global Paclitaxel-eluting Stent Revenue Market Share Forecast by Regions ((2021-2026))
Figure 90. Global Paclitaxel-eluting Stent Production Forecast by Regions (2021-2026) (K Units)
Figure 91. North America Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 92. North America Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 93. Europe Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 94. Europe Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 95. China Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 96. China Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 97. Japan Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 98. Japan Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Global Paclitaxel-eluting Stent Consumption Market Share Forecast by Region (2021-2026)
Figure 100. Paclitaxel-eluting Stent Value Chain
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed
Figure 1. Paclitaxel-eluting Stent Product Picture
Figure 2. Global Paclitaxel-eluting Stent Production Market Share by Type in 2020 & 2026
Figure 3. Metal Stent Product Picture
Figure 4. Polymer Stent Product Picture
Figure 5. Others Product Picture
Figure 6. Global Paclitaxel-eluting Stent Consumption Market Share by Application in 2020 & 2026
Figure 7. Coronary Heart Disease
Figure 8. Clinical
Figure 9. Others
Figure 10. Paclitaxel-eluting Stent Report Years Considered
Figure 11. Global Paclitaxel-eluting Stent Revenue 2015-2026 (Million US$)
Figure 12. Global Paclitaxel-eluting Stent Production Capacity 2015-2026 (K Units)
Figure 13. Global Paclitaxel-eluting Stent Production 2015-2026 (K Units)
Figure 14. Global Paclitaxel-eluting Stent Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 15. Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Paclitaxel-eluting Stent Production Share by Manufacturers in 2015
Figure 17. The Top 10 and Top 5 Players Market Share by Paclitaxel-eluting Stent Revenue in 2019
Figure 18. Global Paclitaxel-eluting Stent Production Market Share by Region (2015-2020)
Figure 19. Paclitaxel-eluting Stent Production Growth Rate in North America (2015-2020) (K Units)
Figure 20. Paclitaxel-eluting Stent Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 21. Paclitaxel-eluting Stent Production Growth Rate in Europe (2015-2020) (K Units)
Figure 22. Paclitaxel-eluting Stent Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 23. Paclitaxel-eluting Stent Production Growth Rate in China (2015-2020) (K Units)
Figure 24. Paclitaxel-eluting Stent Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 25. Paclitaxel-eluting Stent Production Growth Rate in Japan (2015-2020) (K Units)
Figure 26. Paclitaxel-eluting Stent Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 27. Global Paclitaxel-eluting Stent Consumption Market Share by Regions 2015-2020
Figure 28. North America Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 29. North America Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 30. North America Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 31. U.S. Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Canada Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 35. Europe Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 36. Germany Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. France Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. U.K. Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Italy Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Russia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Asia Pacific Paclitaxel-eluting Stent Consumption and Growth Rate (K Units)
Figure 42. Asia Pacific Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 43. Asia Pacific Paclitaxel-eluting Stent Consumption Market Share by Regions in 2019
Figure 44. China Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Japan Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. India Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Australia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Taiwan Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Indonesia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Thailand Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Malaysia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Philippines Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Vietnam Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Latin America Paclitaxel-eluting Stent Consumption and Growth Rate (K Units)
Figure 56. Latin America Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 57. Latin America Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 58. Mexico Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Brazil Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Argentina Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Middle East and Africa Paclitaxel-eluting Stent Consumption and Growth Rate (K Units)
Figure 62. Middle East and Africa Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 63. Middle East and Africa Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 64. Turkey Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Saudi Arabia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. U.A.E Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Global Paclitaxel-eluting Stent Production Market Share by Type (2015-2020)
Figure 68. Global Paclitaxel-eluting Stent Production Market Share by Type in 2019
Figure 69. Global Paclitaxel-eluting Stent Revenue Market Share by Type (2015-2020)
Figure 70. Global Paclitaxel-eluting Stent Revenue Market Share by Type in 2019
Figure 71. Global Paclitaxel-eluting Stent Production Market Share Forecast by Type (2021-2026)
Figure 72. Global Paclitaxel-eluting Stent Revenue Market Share Forecast by Type (2021-2026)
Figure 73. Global Paclitaxel-eluting Stent Market Share by Price Range (2015-2020)
Figure 74. Global Paclitaxel-eluting Stent Consumption Market Share by Application (2015-2020)
Figure 75. Global Paclitaxel-eluting Stent Value (Consumption) Market Share by Application (2015-2020)
Figure 76. Global Paclitaxel-eluting Stent Consumption Market Share Forecast by Application (2021-2026)
Figure 77. B.Braun Melsengen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Biosensors Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Biotronik Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Blue Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. DISA Vascular Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Essen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Medtronic Vascular Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. MicroPort Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Terumo Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Orbusneich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Global Paclitaxel-eluting Stent Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 89. Global Paclitaxel-eluting Stent Revenue Market Share Forecast by Regions ((2021-2026))
Figure 90. Global Paclitaxel-eluting Stent Production Forecast by Regions (2021-2026) (K Units)
Figure 91. North America Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 92. North America Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 93. Europe Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 94. Europe Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 95. China Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 96. China Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 97. Japan Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 98. Japan Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Global Paclitaxel-eluting Stent Consumption Market Share Forecast by Region (2021-2026)
Figure 100. Paclitaxel-eluting Stent Value Chain
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed